Search Results - "ROLKA, DEBORAH B."

Projection of the future diabetes burden in the United States through 2060 by Lin, Ji, Thompson, Theodore J, Cheng, Yiling J, Zhuo, Xiaohui, Zhang, Ping, Gregg, Edward, Rolka, Deborah B

“…In the United States, diabetes has increased rapidly, exceeding prior predictions. Projections of the future diabetes burden need to reflect changes in…”
Get full text

Income-related inequalities in diagnosed diabetes prevalence among US adults, 2001-2018 by Chen, Yu, Zhou, Xilin, Bullard, Kai McKeever, Zhang, Ping, Imperatore, Giuseppina, Rolka, Deborah B

“…The overall prevalence of diabetes has increased over the past two decades in the United States, disproportionately affecting low-income populations. We aimed…”
Get full text

State-Level Awareness of Chronic Kidney Disease in the U.S by Dharmarajan, Sai H., MS, Bragg-Gresham, Jennifer L., MS, PhD, Morgenstern, Hal, PhD, Gillespie, Brenda W., PhD, Li, Yi, PhD, Powe, Neil R., MD, Tuot, Delphine S., MDCM, Banerjee, Tanushree, PhD, Burrows, Nilka Ríos, MPH, Rolka, Deborah B., MS, Saydah, Sharon H., PhD, Saran, Rajiv, MD

“…Introduction This study examined state-level variation in chronic kidney disease (CKD) awareness using national estimates of disease awareness among adults in…”
Get full text

Regional and rural-urban patterns in the prevalence of diagnosed hypertension among older U.S. adults with diabetes, 2005-2017 by Uddin, Jalal, Zhu, Sha, Malla, Gargya, Levitan, Emily B, Rolka, Deborah B, Carson, April P, Long, D Leann

“…Hypertension prevalence among the overall US adult population has been relatively stable during the last two decades. However, whether this stabilization has…”
Get full text

Risk of Cardiovascular Disease After COVID-19 Diagnosis Among Adults With and Without Diabetes by Koyama, Alain K, Imperatore, Giuseppina, Rolka, Deborah B, Lundeen, Elizabeth, Rutkowski, Rachel E, Jackson, Sandra L, He, Siran, Kuklina, Elena V, Park, Soyoun, Pavkov, Meda E

“…Background Growing evidence suggests incident cardiovascular disease (CVD) may be a long-term outcome of COVID-19 infection, and chronic diseases, such as…”
Get full text

Changes in Utilization and Expenditures Among Commercially Insured U.S. Adults With Diabetes During the COVID-19 Pandemic: Preliminary Findings by Zhou, Xilin, Lundeen, Elizabeth A., Rolka, Deborah B.

“…•Utilization dropped in commercially insured persons with diabetes during the pandemic.•The reduction was largest between March 2020 and May 2020 but persisted…”
Get full text

Implications of Alternative Definitions of Prediabetes for Prevalence in U.S. Adults by James, Cherie, Bullard, Kai McKeever, Rolka, Deborah B, Geiss, Linda S, Williams, Desmond E, Cowie, Catherine C, Albright, Ann, Gregg, Edward W

“…OBJECTIVE: To compare the prevalence of prediabetes using A1C, fasting plasma glucose (FPG), and oral glucose tolerance test (OGTT) criteria, and to examine…”
Get full text

Association Between Hypertension and Diabetes Control and COVID-19 Severity: National Patient-Centered Clinical Research Network, United States, March 2020 to February 2022 by Jackson, Sandra L, Woodruff, Rebecca C, Nagavedu, Kshema, Fearrington, Julia, Rolka, Deborah B, Twentyman, Evelyn, Carton, Thomas W, Puro, Jon, Denson, Joshua L, Kappelman, Michael D, Paranjape, Anuradha, Thacker, Deepika, Weiner, Mark G, Goodman, Alyson B, Lekiachvili, Akaki, Boehmer, Tegan K, Block, Jason P

“…Background Hypertension and diabetes are associated with increased COVID-19 severity. The association between level of control of these conditions and COVID-19…”
Get full text

Modeling County-Level Rare Disease Prevalence Using Bayesian Hierarchical Sampling Weighted Zero-Inflated Regression by Xie, Hui, Rolka, Deborah B., Barker, Lawrence E.

“…Estimates of county-level disease prevalence have a variety of applications. Such estimation is often done via model-based small-area estimation using survey…”
Get full text

Urban and rural differences in new onset type 2 diabetes: Comparisons across national and regional samples in the diabetes LEAD network by McAlexander, Tara P., Malla, Gargya, Uddin, Jalal, Lee, David C., Schwartz, Brian S., Rolka, Deborah B., Siegel, Karen R., Kanchi, Rania, Pollak, Jonathan, Andes, Linda, Carson, April P., Thorpe, Lorna E., McClure, Leslie A.

“…Geographic disparities in diabetes burden exist throughout the United States (US), with many risk factors for diabetes clustering at a community or…”
Get full text

Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016 by Andes, Linda J, Cheng, Yiling J, Rolka, Deborah B, Gregg, Edward W, Imperatore, Giuseppina

“…Individuals with prediabetes are at increased risk of developing type 2 diabetes, chronic kidney disease, and cardiovascular disease. The incidence and…”
Get more information

Comparison of surveillance-based metrics for the assessment and monitoring of disease detection: simulation study about type 2 diabetes by Brinks, Ralph, Hoyer, Annika, Rolka, Deborah B, Kuss, Oliver, Gregg, Edward W

“…Screening and detection of cases are a common public health priority for treatable chronic conditions with long subclinical periods. However, the validity of…”
Get full text

INCORPORATING DESIGN WEIGHTS AND HISTORICAL DATA INTO MODEL-BASED SMALL-AREA ESTIMATION by Xie, Hui, Barker, Lawrence E., Rolka, Deborah B.

“…Bayesian hierarchical regression (BHR) is often used in small area estimation (SAE). BHR conditions on the samples. Therefore, when data are from a complex…”
Get full text

Association of community socioeconomic deprivation with evidence of reduced kidney function at time of type 2 diabetes diagnosis by Hirsch, Annemarie G., Nordberg, Cara M., Chang, Alexander, Poulsen, Melissa N., Moon, Katherine A., Siegel, Karen R., Rolka, Deborah B., Schwartz, Brian S.

“…While there are known individual-level risk factors for kidney disease at time of type 2 diabetes diagnosis, little is known regarding the role of community…”
Get full text

COVID-19 Outcomes Stratified by Control Status of Hypertension and Diabetes: Preliminary Findings From PCORnet, U.S by Jackson, Sandra L., Block, Jason P., Rolka, Deborah B., Pavkov, Meda E., Chevinsky, Jennifer R., Lekiachvili, Akaki, Carton, Thomas W., Thacker, Deepika, Denson, Joshua L., Paranjape, Anuradha, Kappelman, Michael D., Boehmer, Tegan K., Twentyman, Evelyn

“…•Among 656,049 adults with COVID-19, 41% had hypertension, and 13% had diabetes.•Approximately one quarter of those with hypertension had blood pressure…”
Get full text

Decreases in Diabetes-Free Life Expectancy in the U.S. and the Role of Obesity by Cunningham, Solveig A, Riosmena, Fernando, Wang, Jing, Boyle, James P, Rolka, Deborah B, Geiss, Linda S

“…OBJECTIVE: With increasing life expectancy in the U.S., it is important to know whether a longer life expectancy means a longer healthy life span or a…”
Get full text

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program by Ely, Elizabeth K, Gruss, Stephanie M, Luman, Elizabeth T, Gregg, Edward W, Ali, Mohammed K, Nhim, Kunthea, Rolka, Deborah B, Albright, Ann L

“…To assess participant-level results from the first 4 years of implementation of the National Diabetes Prevention Program (National DPP), a national effort to…”
Get full text

1002-P: Health Care Utilization among Telehealth Users and Nonusers with Diabetes during the COVID-19 Pandemic—Results from National Medicare Claims by SHAO, YIXUE, WANG, YU, ZHOU, XILIN, ROLKA, DEBORAH B., ZHANG, PING

“…Little is known on differences in healthcare utilization between telehealth users (USER) and non-users (NON-USER) in persons with diabetes mellitus (DM) during…”
Get full text

993-P: Changes in Medical Expenditures and Out-of-Pocket Costs in Medicare Beneficiaries with Diabetes during the COVID-19 Pandemic by WANG, YU, ZHANG, PING, ZHOU, XILIN, ROLKA, DEBORAH B., IMPERATORE, GIUSEPPINA

“…How COVID-19 has affected payers and persons with diabetes mellitus (DM) is not well understood. We compared total and per capita medical expenditures and…”
Get full text

998-P: Changes in Health Care Utilization and Costs among Commercially Insured U.S. Adults with Diabetes during the COVID-19 Pandemic by ZHOU, XILIN, LUNDEEN, ELIZABETH A., ROLKA, DEBORAH B.

“…Using claims from IQVIA PharMetrics Plus, we examined changes in health care utilization and costs among commercially insured US adults (aged 18 to 64 years)…”
Get full text